Zhengye Biotechnology Holding (ZYBT) Debt to Equity (2023 - 2025)
Historic Debt to Equity for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $0.01.
- Zhengye Biotechnology Holding's Debt to Equity changed N/A to $0.01 in Q2 2025 from the same period last year, while for Jun 2025 it was $0.01, marking a year-over-year change of. This contributed to the annual value of $0.03 for FY2024, which is 8715.78% down from last year.
- Zhengye Biotechnology Holding's Debt to Equity amounted to $0.01 in Q2 2025.
- Zhengye Biotechnology Holding's 5-year Debt to Equity high stood at $0.26 for Q4 2023, and its period low was $0.01 during Q2 2025.
- For the 3-year period, Zhengye Biotechnology Holding's Debt to Equity averaged around $0.1, with its median value being $0.03 (2024).
- Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Debt to Equity was 8715.78% (2024), while the steepest drop was 8715.78% (2024).
- Quarter analysis of 3 years shows Zhengye Biotechnology Holding's Debt to Equity stood at $0.26 in 2023, then plummeted by 87.16% to $0.03 in 2024, then tumbled by 60.54% to $0.01 in 2025.
- Its last three reported values are $0.01 in Q2 2025, $0.03 for Q4 2024, and $0.26 during Q4 2023.